Siyanda Mazaleni

Ms. Siyanda Mazaleni

University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AFAshmika Foolchand
Ashmika Foolchand
SMSiyanda Mazaleni
Siyanda Mazaleni
TGTerisha Ghazi
Terisha Ghazi
ACAnil Chuturgoon
Anil Chuturgoon
The highly transmittable and infectious COVID-19 remains a major threat worldwide, with the elderly and comorbid individuals being the most vulnerable. While vaccines are currently available, therapeutic drugs will help ease the viral outbreak and prevent serious health outcomes. Epigenetic modifications regulate gene expression through changes in chromatin structure and have been linked to viral pathophysiology. Since epigenetic modifications contribute to the life cycle of the virus and host immune responses to infection, epigenetic drugs are promising treatment targets to ameliorate COVID-19. Deficiency of the multifunctional secosteroid hormone vitamin D is a global health threat. Vitamin D and its receptor function to regulate genes involved in immunity, apoptosis, proliferation, differentiation, and inflammation. Amassed evidence also indicates the biological relations of vitamin D with reduced disease risk, while its receptor can be modulated by epigenetic mechanisms. The immunomodulatory effects of vitamin D suggest a role for vitamin D as a COVID-19 therapeutic agent. Therefore, this review highlights the epigenetic effects on COVID-19 and vitamin D while also proposing a role for vitamin D in COVID-19 infections.

29 April 2026 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
SMSiyanda Mazaleni
Siyanda Mazaleni
TGTerisha Ghazi
Terisha Ghazi
ACAnil Chuturgoon
Anil Chuturgoon
RBRajendra Bhimma
Rajendra Bhimma
Congenital anomalies of the kidney and urinary tract (CAKUT) consist of a wide range of malformations. During fetal development, these changes result in defects in the morphology and function of the kidneys and/or urinary tract and represent 23% of all congenital disabilities. This review aimed to highlight the prevalence and contribution of CAKUT to chronic kidney failure (CKF) in the African population and explore the current knowledge on genetics influencing the pathogenesis of CAKUT globally. A study conducted in Ethiopia reported CAKUT to be the most common kidney disease (26.8%) in children and infants. Recent studies conducted in East and West Africa reported CAKUT to have a mean prevalence of 4.84% and 8.77%, respectively. Although some studies have shown that less severe manifestations of CAKUT, such as mild obstruction, can have 70–90% resolution, some forms may advance to chronic kidney disease (CKD) and CKF. CAKUT has been reported to be responsible for 15.7–59% of CKD and 4.5–50% of CKF cases in children. Various studies have highlighted the involvement of genetics in the development of CAKUT and the significant number of unidentified genes that are likely to influence its pathogenesis. However, due to the limited studies conducted in Africa, we cannot establish the influence of genetics on CAKUT in Africa.